SIGA Technologies (NASDAQ:SIGA) Stock Rating Upgraded by TheStreet

SIGA Technologies (NASDAQ:SIGAGet Rating) was upgraded by TheStreet from a “c+” rating to a “b” rating in a research note issued on Monday, TheStreetRatingsTable reports.

Separately, Zacks Investment Research cut shares of SIGA Technologies from a “buy” rating to a “hold” rating in a report on Thursday, January 6th.

Shares of SIGA opened at $6.96 on Monday. The firm’s 50 day simple moving average is $6.78 and its 200 day simple moving average is $7.16. The company has a market capitalization of $508.29 million, a P/E ratio of 7.57 and a beta of 0.50. SIGA Technologies has a 1-year low of $5.66 and a 1-year high of $9.82.

SIGA Technologies (NASDAQ:SIGAGet Rating) last issued its quarterly earnings results on Thursday, March 3rd. The company reported $0.98 EPS for the quarter. SIGA Technologies had a net margin of 51.94% and a return on equity of 53.39%. The business had revenue of $115.40 million for the quarter. As a group, research analysts anticipate that SIGA Technologies will post 0.64 EPS for the current year.

A number of institutional investors have recently made changes to their positions in SIGA. Royal Bank of Canada lifted its position in SIGA Technologies by 39.4% during the third quarter. Royal Bank of Canada now owns 7,516 shares of the company’s stock valued at $56,000 after buying an additional 2,126 shares during the period. BNP Paribas Arbitrage SA lifted its position in SIGA Technologies by 378.2% during the third quarter. BNP Paribas Arbitrage SA now owns 8,951 shares of the company’s stock valued at $66,000 after buying an additional 7,079 shares during the period. Citigroup Inc. lifted its position in SIGA Technologies by 18.1% during the third quarter. Citigroup Inc. now owns 10,299 shares of the company’s stock valued at $76,000 after buying an additional 1,575 shares during the period. Principal Financial Group Inc. purchased a new position in SIGA Technologies during the third quarter valued at $79,000. Finally, Qube Research & Technologies Ltd purchased a new position in SIGA Technologies during the fourth quarter valued at $82,000. 33.45% of the stock is owned by institutional investors and hedge funds.

SIGA Technologies Company Profile (Get Rating)

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats.

Further Reading

Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.